These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6340975)

  • 1. Breathlessness and exercise tolerance in chronic airflow obstruction: 2-hourly versus 4-hourly salbutamol by inhalation.
    Shah SS; Johnston D; Woodcock AA; Johnson M; Geddes DM
    Curr Med Res Opin; 1983; 8(5):345-9. PubMed ID: 6340975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.
    Papiris S; Galavotti V; Sturani C
    Respiration; 1986; 49(2):101-8. PubMed ID: 3513269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic airflow limitation.
    Geraghty R; Foster C; Black D; Roe S
    Respir Med; 1993 Jul; 87(5):375-8. PubMed ID: 8209057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation.
    Jenkins SC; Heaton RW; Fulton TJ; Moxham J
    Chest; 1987 Jun; 91(6):804-7. PubMed ID: 3556051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.
    Corris PA; Neville E; Nariman S; Gibson GJ
    Thorax; 1983 Apr; 38(4):292-6. PubMed ID: 6867983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.
    Grove A; Lipworth BJ; Reid P; Smith RP; Ramage L; Ingram CG; Jenkins RJ; Winter JH; Dhillon DP
    Thorax; 1996 Jul; 51(7):689-93. PubMed ID: 8882074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of nebulized salbutamol on lung function and exercise tolerance in patients with severe airflow obstruction.
    Connellan SJ; Gough SE
    Br J Dis Chest; 1982 Apr; 76(2):135-42. PubMed ID: 7093130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases.
    Woodcock AA; Gross ER; Gellert A; Shah S; Johnson M; Geddes DM
    N Engl J Med; 1981 Dec; 305(27):1611-6. PubMed ID: 6796885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
    Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eaton ML; MacDonald FM; Church TR; Niewoehner DE
    Chest; 1982 Nov; 82(5):538-42. PubMed ID: 7128220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose salbutamol in chronic airflow obstruction: comparison of nebulizer with Rotacaps.
    Assoufi BK; Hodson ME
    Respir Med; 1989 Sep; 83(5):415-20. PubMed ID: 2616824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.
    Guyatt GH; Townsend M; Pugsley SO; Keller JL; Short HD; Taylor DW; Newhouse MT
    Am Rev Respir Dis; 1987 May; 135(5):1069-74. PubMed ID: 3579005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrocodeine for breathlessness in "pink puffers".
    Johnson MA; Woodcock AA; Geddes DM
    Br Med J (Clin Res Ed); 1983 Feb; 286(6366):675-7. PubMed ID: 6402199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Response to inhaled bronchodilators in chronic airway obstruction].
    Holten K
    Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
    Thomas P; Pugsley JA; Stewart JH
    Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.
    Karpel JP; Kotch A; Zinny M; Pesin J; Alleyne W
    Chest; 1994 Apr; 105(4):1089-94. PubMed ID: 8162730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pharmacological study of a novel controlled release preparation of salbutamol.
    Milroy R; Carter R; Carlyle D; Boyd G
    Br J Clin Pharmacol; 1990 May; 29(5):578-80. PubMed ID: 2190630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose and steady-state effects of controlled-release salbutamol on drug level and airflow obstruction in patients with asthma.
    Tan WC; Chan TB; Ang SM
    Singapore Med J; 1992 Aug; 33(4):371-4. PubMed ID: 1411667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.